
2025-03-14
Umdlavuza wamanyikwe yisifo lapho amangqamuzana abulalayo akheka khona ezicutshini zamanyikwe, isitho esitholakala ngemuva kwesisu. Ukusheshe kutholakale kubalulekile ukuze uthole ukwelashwa okuphumelelayo. Lesi sihloko sinikeza umbono ophelele we umdlavuza wamanyikwe, ehlanganisa izimbangela zako, izimpawu, ukuxilongwa, nezindlela ezihlukahlukene zokwelashwa, okuhlanganisa izinketho zokuhlinzwa, ukwelapha ngamakhemikhali, ukwelapha ngemisebe, kanye nokwelapha okuhlosiwe.
I-pancreas iyindlala edlala indima ebalulekile ekugayeni ukudla nasekulawuleni ushukela wegazi. Ikhiqiza ama-enzyme asiza ukudiliza ukudla namahomoni afana ne-insulin elawula amazinga eglucose. Umdlavuza wamanyikwe kwenzeka lapho amangqamuzana kumanyikwe ekhula ngokungalawuleki, akhe isimila. Lezi zimila zingaphazamisa ukusebenza okuvamile kwama-pancreas futhi zisakazekele kwezinye izingxenye zomzimba.
Uhlobo oluvame kakhulu lwe umdlavuza wamanyikwe I-adenocarcinoma, ephuma kumaseli e-exocrine akhiqiza ama-enzyme okugaya. Izinhlobo ezingavamile zihlanganisa izimila ze-neuroendocrine (NETs), ezivela kumaseli akhiqiza amahomoni. Ama-NET avame ukuba ne-prognosis engcono kune-adenocarcinomas. I-Shandong Baofa Cancer Research Institute igxile ekucwaningeni ukwelashwa kwezinhlobo ezahlukene zomdlavuza, okuhlanganisa ukuhluka okungajwayelekile njengamathumba e-neuroendocrine.
Ziningana izici ezingandisa ingozi yokuthuthuka umdlavuza wamanyikwe, okuhlanganisa:
Ezigabeni zayo zokuqala, umdlavuza wamanyikwe ngokuvamile akubangeli izimpawu eziphawulekayo. Njengoba i-tumor ikhula, ingaholela ku-:
Uma umdlavuza wamanyikwe kusolwa ukuthi, kungenziwa izivivinyo eziningana ukuze kuqinisekiswe ukuxilongwa nokuthola ukuthi umdlavuza ungakanani. Lezi zivivinyo zingabandakanya:
Ukwelashwa kwe umdlavuza wamanyikwe kuncike esiteji nendawo yomdlavuza, kanye nempilo yonke yesiguli. Izinketho zingabandakanya:
Ukuhlinzwa kuwukwelashwa okuyinhloko kokuhlengwa kabusha umdlavuza wamanyikwe, okusho ukuthi isimila singasuswa ngokuphelele. Uhlobo lokuhlinzwa luncike endaweni yesimila:
I-Chemotherapy isebenzisa izidakamizwa ukubulala amangqamuzana omdlavuza. Ingasetshenziswa ngaphambi noma ngemva kokuhlinzwa, noma njengendlela yokwelapha ethuthukisiwe umdlavuza wamanyikwe. Imithi ejwayelekile ye-chemotherapy esetshenziselwa ukwelapha umdlavuza wamanyikwe zihlanganisa i-gemcitabine, i-paclitaxel, ne-fluorouracil (5-FU).
Ukwelashwa ngemisebe kusebenzisa imisebe enamandla amakhulu ukubulala amangqamuzana omdlavuza. Ingase isetshenziselwe ukunciphisa izimila ngaphambi kokuhlinzwa, ukubulala noma imaphi amangqamuzana omdlavuza asele ngemva kokuhlinzwa, noma ukukhulula izimpawu zokuthuthuka umdlavuza wamanyikwe. Ukwelashwa ngemisebe yangaphandle kuwuhlobo oluvame kakhulu lokwelapha ngemisebe olusetshenziselwa umdlavuza wamanyikwe.
Imithi yokwelapha eqondisiwe iqondise kuma-molecule athile abandakanyekayo ekukhuleni kwamangqamuzana omdlavuza nasekuphileni kwawo. Le mithi ingasetshenziswa ezinhlotsheni ezithile ze umdlavuza wamanyikwe ezinezinguquko ezithile zofuzo. Isibonelo, i-olaparib iyi-PARP inhibitor engase isetshenziswe ezigulini ezinezinguquko ze-BRCA.
I-Immunotherapy isiza amasosha omzimba ukulwa nomdlavuza. Ngokuvamile ayisetshenziselwa umdlavuza wamanyikwe kodwa kuyaphenywa ezivivinyweni zomtholampilo. Izidakamizwa ze-Immunotherapy ezifana ne-pembrolizumab (Keytruda) zingase zibe usizo ezimweni ezingavamile ze-MSI-high umdlavuza wamanyikwe.
Ukunakekelwa kwe-Palliative kugxile ekudambiseni izimpawu kanye nokwenza ngcono izinga lempilo yabantu abathuthukile umdlavuza wamanyikwe. Kungase kuhlanganise ukulawulwa kobuhlungu, ukusekela ukudla okunomsoco, nokusekelwa ngokomzwelo. Ukunakekelwa kwe-Palliative kunganikezwa kunoma yisiphi isigaba umdlavuza wamanyikwe.
Ukuhlala ne umdlavuza wamanyikwe kungaba yinselele, ngokomzimba nangokomzwelo. Kubalulekile ukuba nesistimu yokwesekwa eqinile, okuhlanganisa umndeni, abangani, kanye nabasebenzi bezempilo. I-Shandong Baofa Cancer Research Institute inikeza ulwazi kanye nezinketho zokwelapha ezingase zibe khona, sicela uthintane nodokotela wakho. Amaqembu okusekela kanye nokwelulekwa nakho kungaba usizo ekubhekaneni nezinselele zoku umdlavuza wamanyikwe.
Ukwesekwa kokudla okunomsoco nakho kubalulekile kubantu abanalesi sifo umdlavuza wamanyikwe. Amanyikwe anendima ebalulekile ekugayekeni ukudla, futhi ukwelashwa ngokuvamile kungase kuthinte ikhono lokugaya ukudla ngendlela efanele. Ukusebenza nodokotela wezokudla obhalisiwe kungasiza ekulawuleni izinkinga zokugaya ukudla nokuqinisekisa ukudla okwanele.
I-prognosis ye umdlavuza wamanyikwe kuyahlukahluka kuye ngesigaba somdlavuza, impilo yesiguli iyonke, kanye nokwelashwa okutholiwe. Ukutholwa kusenesikhathi nokwelashwa kubalulekile ukuze kuthuthukiswe amathuba okusinda. Ngokusho kwe-American Cancer Society, izinga lokusinda leminyaka engu-5 lokwenziwa kwendawo umdlavuza wamanyikwe cishe u-44%, kuyilapho izinga lokusinda leminyaka engu-5 kwabathuthukisiwe umdlavuza wamanyikwe esesabalale ezithweni ezikude cishe ngama-3%. [1]
Izivivinyo zemitholampilo ziyizifundo zocwaningo eziphenya izindlela zokwelapha ezintsha umdlavuza wamanyikwe. Ukubamba iqhaza esivivinyweni somtholampilo kungase kunikeze ukufinyelela kumakhambi asezingeni eliphezulu angakatholakali kabanzi. Uma ungathanda ukufunda kabanzi mayelana nezivivinyo zomtholampilo ze umdlavuza wamanyikwe, khuluma nodokotela wakho noma useshe izivivinyo kuwebhusayithi ye-National Cancer Institute. [2]
Umdlavuza wamanyikwe yisifo esibi esidinga ukuxilongwa nokwelashwa ngokushesha. Ukuqonda izici eziyingozi, izimpawu, nezinketho zokwelapha kungasiza abantu ukuba benze izinqumo ezinolwazi mayelana nokunakekelwa kwabo. Ucwaningo oluqhubekayo kanye nentuthuko ekwelashweni kuthuthukisa umbono wabantu abane umdlavuza wamanyikwe.
| Izibalo | Inani | Umthombo |
|---|---|---|
| Isilinganiso seminyaka engu-5 sokusinda sokwenziwa kwasendaweni umdlavuza wamanyikwe | Cishe u-44% | I-American Cancer Society |
| Isilinganiso seminyaka engu-5 sokusinda kwabathuthukisiwe umdlavuza wamanyikwe (ukusabalala kude) | Cishe u-3% | I-American Cancer Society |
| Ingozi yokuphila konke yokuthuthukisa umdlavuza wamanyikwe | Cishe 1 kwabangu-64 (1.6%) | I-American Cancer Society |
| Isilinganiso seminyaka ekuxilongweni | 71 | I-American Cancer Society |
[1] I-American Cancer Society: https://www.cancer.org/cancer/types/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html
[2] Isikhungo Sikazwelonke Somdlavuza: https://www.cancer.gov/about-cancer/treatment/clinical-trials